Morbid Obesity. Overweight and obesity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: patients aged between 18 and 65 years morbidly-obese patients candidates for bariatric surgery , BMI above 40 kg/m2
Exclusion criteria
Exclusion criteria: Chronic damage to the digestive system, liver and kidney Insulin use within 4 weeks before the start of the study and during the study Patients with micronutrient deficiency of vitamin D, folic acid and iron storage Pregnant patients Consuming foods enriched with probiotics within 4 weeks before the start of the study and during the study Corticistreoid consumption within 4 weeks before the start of the study and during the study Taking immunosuppressive drugs within 4 weeks before the start of the study and during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BMI (body mass index). Timepoint: Before, three and six months after the intervention. Method of measurement: scale.;Fat mass. Timepoint: Before, three and six months after the intervention. Method of measurement: According to the measurement of anthropometric index with the inbody 370 bioimpedance analyzer (Biospace America, Inc.).;Muscle mass. Timepoint: Before, three and six months after the intervention. Method of measurement: According to the measurement of anthropometric index with the inbody 370 bioimpedance analyzer (Biospace America, Inc.).;Excess body weight loss. Timepoint: Before, three and six months after the intervention. Method of measurement: Calculation based on the difference between the patient's weight and the difference between the preoperative weight and the ideal weight. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences